Subclinical Plasmodium falciparum infection and HIV-1 viral load [9]

Emerging Infectious Diseases

Volumn 13, Issue 2, 2007, Pages 351-353

  Brouwer, Kimberly C ^a,e   Mirel, Lisa B ^a   Yang, Chunfu ^a   Lal, Renu B ^a   Kolczak, Margarette S ^a   Van Eijk, Anne M ^b   Ayisi, John ^b   Otieno, Juliana A ^c   Nahlen, Bernard L ^a,d   Steketee, Richard ^a   Ya, Ping Shi ^a,b   Lal, Altaf A ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c New Nyanza Provincial General Hospital   (Kenya)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; FANSIDAR;

HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MALARIA; MORBIDITY; NONHUMAN; PLASMODIUM FALCIPARUM; PROTOZOAL INFECTION; VIRUS LOAD; VIRUS REPLICATION;

EID: 33846664215     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1302.060573     Document Type: Letter

References (10)

1. Hoffman IF, Jere CS, Taylor TE, Munthali P, Dyer JR, Wirima JJ, et al. The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration. AIDS. 1999;13:487-94.
2. Kublin JG, Patnaik P, Jere CS, Miller WC, Hoffman IF, Chimbiya N, et al. Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study. Lancet. 2005;365:233-40.
3. Rogers MF, Thomas PA, Starcher ET, Noa MC, Bush TJ, Jaffe HW. Acquired immunodeficiency syndrome in children: report of the Centers for Disease Control National Surveillance, 1982 to 1985. Pediatrics. 1987;79:1008-14.
4. Pizzo PA, Wilfert CM. Markers and determinants of disease progression in children with HIV infection. The Pediatric AIDS Siena Workshop II. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8:30-44.
5. Ayisi JG, van Eijk AM, ter Kuile FO, Kolczak MS, Otieno JA, Misore AO, et al. Risk factors for HIV infection among asymptomatic pregnant women attending an antenatal clinic in western Kenya. Int J STD AIDS. 2000;11:393-401.
6. Ayisi JG, van Eijk AM, Newman RD, ter Kuile FO, Shi YP, Yang C, et al. Maternal malaria infection and perinatal HIV transmission, western Kenya. Emerg Infect Dis. 2004;10:643-52.
7. Yang C, Li M, Newman RD, Shi YP, Ayisi J, van Eijk AM, et al. Genetic diversity of HIV-1 in western Kenya: subtype-specific differences in mother-to-child transmission. AIDS. 2003;17:1667-74.
8. Bloland PB, Boriga DA, Ruebush TK, McCormick JB, Roberts JM, Oloo AJ, et al. Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission II. Descriptive epidemiology of malaria infection and disease among children. Am J Trop Med Hyg. 1999;60:641-8.
9. Greenberg AE, Nsa W, Ryder RW, Medi M, Nzeza M, Kitadi N, et al. Plasmodium falciparum malaria and perinatally acquired human immunodeficiency virus type 1 infection in Kinshasa, Zaire. A prospective, longitudinal cohort study of 587 children. N Engl J Med. 1991;325:105-9.
10. Kalyesubula I, Musoke-Mudido P, Marum L, Bagenda D, Aceng E, Ndugwa C, et al. Effects of malaria infection in human immunodeficiency virus type 1-infected Ugandan children. Pediatr Infect Dis J. 1997;16:876-81.